USPTO serial 99947883
PHACTORY
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROSS, TRACY L
- Law office
- TMEG LAW OFFICE 109
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with PHACTORY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Planegg-Martinsried, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Berkowitz, PC200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific purposes; Reagents for medical research; Reagents for research purposes; Testing reagents for scientific use; Laboratory reagents for scientific use | ACTIVE | — |
| 005 | (Based on 44(e))(Based on Intent to Use) Antibacterial pharmaceuticals; Anti-bacterial preparations; Antibacterial preparations, namely sprays, creams or devices for intravenous use; Antibacterial substances for medical purposes; Antibiotics; Anti-infectives; Antimicrobial preparations for preventing infections; Antimicrobial preparations for treating infections; Anti-microbial preparations; Antimicrobial preparations for the control of biofilms and for inhibiting bacteria; Bacteriological preparations for medical purposes; Bacteriological preparations for pharmaceutical use; Bacteriophages; Biological preparations for the treatment of neurodegenerative diseases; Biological reagents for medical use; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use; Drugs for medical use; Pharmaceutical drugs; Pharmaceutical preparations for the treatment of viral infections; Fodder additives for medical purposes; Medicine; Anti-cancer preparations of microbial origin; Reagents for microbiological analysis for medical purposes; Preparations for microbiome modulation; Chemical preparations for pharmaceutical purposes; Pharmaceutical compositions; Pharmaceutical preparations and substances; Pharmaceutical preparations for the prevention of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations, namely, antivirals; Pharmaceuticals; Protein arrays for diagnosing cancer; Protein synthesis inhibitors; Regulatory proteins for medical use; Food supplements for veterinary use (Based on 44(e))(Based on 44(d) Priority Application)(Based on Intent to Use) Drugs for the prevention and treatment of infectious diseases; Food supplements for medical purposes for humans and animals | ACTIVE | — |
| 040 | Custom manufacturing of proteins, nucleic acids, metabolites and other biomolecules for others using cell free biosynthesis systems; Contract manufacturing in the field of cell free biosynthesis; Manufacturing consultancy relating to cell free biosynthesis | ACTIVE | — |
| 042 | (Based on 44(e))(Based on Intent to Use) Bacteriological research; Bacteriological research and testing; Analysis in the field of molecular biology; Biological development services; Biological laboratory services; Biological research, clinical research and medical research; Biomedical research services; Preparation of biological samples for research purposes; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research in the field of synthetic biology; Biotechnology testing; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Information on the subject of scientific research in the field of biochemistry and biotechnology; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Research and development in the pharmaceutical and biotechnology fields; Drug development services; Drug discovery services; Pharmaceutical drug development services; Medical research; Microbiological testing; Conducting early evaluations in the field of new pharmaceuticals; Inspection of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of pharmacy; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Bacteriological research and analysis; Biotechnology research; Clinical research; Consultancy in the field of bacteriological research; Consultancy relating to pharmaceutical research and development; DNA analysis services for scientific research purposes; DNA sequencing technology research; Genetic research; Medical and pharmacological research services; Research and development for the pharmaceutical industry; Research and development in the field of microbiomes; Research and development services, relating to the following sectors: Anti-infectives; Research and development services, relating to the following sectors: Bacteriophages; Research relating to biotechnology; Research and development of vaccines; Research and development services in the field of bacteriology; Research of pharmaceuticals; Scientific research and development; Scientific research for medical purposes; Scientific research in the field of genetics; Veterinary research; Biomedical research services in the field of cell free biosynthesis; Research and development for the pharmaceutical industry in the field of cell free biosynthesis; Pharmaceutical research and development services in the field of cell free biosynthesis; Consultancy relating to pharmaceutical research and development in the field of cell free biosynthesis; Scientific research and development in the field of cell free biosynthesis; Clinical research in the field of cell free biosynthesis; Medical research in the field of cell free biosynthesis; Veterinary research in the field of cell free biosynthesis (Based on 44(e))(Based on 44(d) Priority Application)(Based on Intent to Use) Provision of technical research services; Provision of technical research services in the field of cell free biosynthesis; Biotechnological research in the field of cell free biosynthesis (Based on 44(d) Priority Application)(Based on Intent to Use) Consultancy relating to research and development in the field of therapeutics, in particular cell free biosynthesis | ACTIVE | — |
| 044 | Arranging of medical treatment; DNA screening for medical purposes; Medical services, in relation to the following fields: Bacteriophages; Medical and health services relating to DNA, genetics and genetic testing; Medical consultation; Medical services; Medical testing; Providing information relating to medical services; Provision of medical services; Preparation and dispensing of medications; Pest control in agriculture; Advisory services relating to pharmaceuticals; Pharmaceutical advisory services; Pharmaceutical services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Veterinary and agricultural services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Invitris GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PHACTORY
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 7, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2026 | NWAP | NEW APPLICATION ENTERED | — |